These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37094882)

  • 1. Subcutaneous tranexamic acid for bleeding associated with a mycotic aortic aneurysm.
    Kilpatrick M; Bateman S; Baggott A; Sutherland A
    BMJ Support Palliat Care; 2024 Aug; 14(3):303-304. PubMed ID: 37094882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Arndt G; Wai R; Stiel H
    J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid.
    Geist MJP; Kessler J; Frankenhauser S; Bardenheuer HJ
    J Palliat Care; 2017 Apr; 32(2):47-48. PubMed ID: 28920517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding management in palliative medicine: subcutaneous tranexamic acid - retrospective chart review.
    Howard P; Curtin J
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e802-e806. PubMed ID: 35121592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized Tranexamic Acid as a Noninvasive Therapy for Cancer-Related Hemoptysis.
    Hankerson MJ; Raffetto B; Mallon WK; Shoenberger JM
    J Palliat Med; 2015 Dec; 18(12):1060-2. PubMed ID: 26381600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tranexamic acid in haemoptysis: A randomized, controlled pilot study.
    Bellam BL; Dhibar DP; Suri V; Sharma N; Varma SC; Malhotra S; Bhalla A
    Pulm Pharmacol Ther; 2016 Oct; 40():80-3. PubMed ID: 27470681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytic therapy to reduce haemoptysis from any cause.
    Prutsky G; Domecq JP; Salazar CA; Accinelli R
    Cochrane Database Syst Rev; 2012 Apr; (4):CD008711. PubMed ID: 22513965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic therapy to reduce haemoptysis from any cause.
    Prutsky G; Domecq JP; Salazar CA; Accinelli R
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008711. PubMed ID: 27806184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    Low TH; Huang J; Reid C; Elliott M; Clark JR
    Laryngoscope; 2013 Oct; 123(10):2449-52. PubMed ID: 23553514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: use of topical tranexamic acid to stop localised bleeding.
    Noble S; Chitnis J
    Emerg Med J; 2013 Jun; 30(6):509-10. PubMed ID: 22833592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does tranexamic acid stop haemoptysis?
    Moen CA; Burrell A; Dunning J
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):991-4. PubMed ID: 23966576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for nebulized tranexamic acid in veno-venous ECMO patients.
    Cabanilla MG; Villalobos NE; Ahmed S
    J Clin Pharm Ther; 2022 Jan; 47(1):125-128. PubMed ID: 34114243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized Tranexamic Acid Therapy for Hemoptysis Associated with Submassive Pulmonary Embolism.
    Dhanani JA; Roberts J; Reade MC
    J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):12-14. PubMed ID: 31161941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.
    Simon RP; Oromendia C; Sanso LM; Ramos LG; Rajwani K
    Pulm Pharmacol Ther; 2020 Feb; 60():101871. PubMed ID: 31783097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
    Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an anti-fibrinolytic agent to reduce endoleak following endovascular repair of multiple aortic aneurysms.
    Uzuka T; Nakamura M; Kuroda Y; Watanabe N
    Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):266-8. PubMed ID: 25948575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
    Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
    BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment.
    Segrelles Calvo G; De Granda-Orive I; López Padilla D
    Chest; 2016 Feb; 149(2):604. PubMed ID: 26867844
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators
    Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.